Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Increasing incidence of both juvenile-onset Crohn's and UC in Scotland

The incidences of both juvenile-onset Crohn's disease and ulcerative colitis continue to rise in Scotland, according to research published in the December issue of the European Journal of Gastroenterology and Hepatology.

News image

fiogf49gjkf04

Researchers from Edinburgh, Scotland, documented the incidence of juvenile-onset inflammatory bowel disease (IBD) between 1981 and 1995 in Scotland. They also examined the temporal trends between 1968 and 1995.

A previous study reported a 3-fold rise in the incidence of juvenile-onset Crohn's disease (CD), in Scottish children, and a marginal fall in ulcerative colitis (UC) between 1968 and 1983.

Four Scottish urban centers, each with a population of over 100,000, were included in the study.

The Scottish hospital discharges database was used to identify 1002 patients less than 19 years old who were coded as having IBD between 1981 and 1997.

All case notes were reviewed and diagnoses verified.

Incident cases were defined as those with symptom onset before or at 16 years of age, between 1 January 1981 and 31 December 1995.

During the 15-year period, 438 incident cases of CD and 227 of UC were identified, giving standardization incidences of 2.5 CD cases and 1.3 UC cases per 100,000 population per year.

Prevalence of Crohn's has increased by 30% since 1983.
European Journal of Gastroenterology & Hepatology
On 31 December 1995 there were 150 children ≤ 16 years of age with CD and 101 with UC, giving crude prevalences of 13.7 cases per 100,000 population for CD and 9.2 for UC.

The continuing rise in CD incidence between 1981 and 1995 fitted with that predicted by linear trend analysis of the 1968-1983 data.

The team found that the incidence of CD in the 12-16 age range almost doubled between 1981 and 1995, and was far greater for males than females.

UC incidence was thought to show a slight fall in the 1968-1983 data, but this was reversed in the 1981-1995 data.

Author Emma Armitage, of the Western General Hospital, Edinburgh, said on behalf of her colleagues, "The incidence of juvenile-onset CD continues to rise in Scotland. The prevalance has increased by 30% since 1983.

"Unlike the previous report form Scotland, the incidence of juvenile-onset UC is also apparently rising."

"Whether this represents a real rise in incidence, or merely the inclusion of milder cases, which were not previously hospitalized, remains uncertain," she concluded.

Eur J Gastroenterol Hepatol 2001; 13 (12): 1439-47
13 December 2001

Go to top of page Email this page Email this page to a colleague

 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Autoimmune pancreatitis in children
 01 November 2017 
Heartburn relief in adolescents with GERD
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us